|
Rosetta Genomics Names Genekor S.A Exclusive Distributor for Three microRNA-based Assays in Greece
REHOVOT, Israel & PHILADELPHIA & ATHENS, Greece----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, and Genekor S.A, a leading molecular diagnostic service provider in Greece, announced today the signing of an exclusive distribution agreement for three of Rosetta Genomics diagnostic tests in Greece.
(Jul 29, 2010)
New Tool For Accessing Bioinformatics Resources
Developed by researchers at the UPM's Facultad de Informática, this tool can discover and automatically classify bioinformatics resources from the scientific literature. Bioinformatics resources have proliferated in the years since the end of the Human Genome Project, obliging researchers to spend a quite a lot of time browsing the web in search of these resources...
(Jul 29, 2010)
Thermo Fisher Scientific Announces Collaboration to Establish New Tokyo Biomarker Research Center
SAN JOSE, Calif. (July 26, 2010) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a landmark collaboration that aims to introduce mass spectrometry-based workflows and technologies into Japan to advance personalized medicine and healthcare. The intent of the collaboration between Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry (BRIMS ...
(Jul 29, 2010)
J. Craig Venter Institute Hosts Genomics Education Program for DC Metro Area Teachers
Program gives teachers in-depth information about exciting advances in genomics
(Jul 29, 2010)
Genekor to Distribute Rosetta Genomics' Assays
NEW YORK (GenomeWeb News) Rosetta Genomics today said that it has granted exclusive distribution rights in Greece for three of its assays to Genekor, an Athens-based molecular diagnostics firm.
(Jul 29, 2010)
WaferGen Announces Purchase of SmartChip Products by Contract Services Company Directed by Founder and Organizer of ...
FREMONT, Calif., July 29 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that DNA Chip Research Inc. (DCRI), a Japanese contract services provider in functional genomics-based technologies and biology directed by the founder and organizer of the Japanese Human Genome Project, has ...
(Jul 29, 2010)
Research and Markets: Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics ...
DUBLIN----Research and Markets has announced the addition of the "Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation" report to their offering.
(Jul 29, 2010)
Research and Markets: Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling ...
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new book "Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling" to their offering.
(Jul 29, 2010)
Natural Language Processing Tool for Bioinformatics
Researchers develop semantic tool for searching bioinformatics resources Natural language processing - Artificial intelligence - Social Sciences - Computational Linguistics - Linguistics
(Jul 29, 2010)
Caltech Researchers Use PEG-tagging to Simplify Study of Glycosylation Stoichiometries
Researchers at the California Institute of Technology have developed a polyethylene glycol-based mass-tagging strategy for the analysis of glycosylated proteins that does not require protein purification, advanced instrumentation, or expensive radiolabels, according to the Caltech team.
(Jul 29, 2010)
ISB Mum on Permit for Renovations to Former Merck Rosetta Research Center Building
NEW YORK (GenomeWeb News) The Institute for Systems Biology isn't discussing a renovation project planned for the former Merck Rosetta Research Center building in Seattle's South Lake Union Section, for which the institute was issued a construction permit along with its architect earlier this month.
(Jul 29, 2010)
Study: Lack of Correlation Between Messenger RNA, Protein Product Levels in Single E. Coli Cells
NEW YORK (GenomeWeb News) In a paper appearing online today in Science , researchers from Harvard University and the University of Toronto report that they have assessed single molecule proteome and transcriptome profiles in individual Escherichia coli cells.
(Jul 29, 2010)
Akonni Wins $435K SBIR Grant to Develop POC Tuberculosis Dx on PCR Array Technology
Akonni Biosystems said this week that it has been awarded a $435,000 grant from the National Institutes of Health to begin developing point-of-care diagnostics for drug-resistant tuberculosis strains based on the company's gel-drop PCR microarray biochip technology.
(Jul 29, 2010)
Regulation could save genome scanning, not kill it
The personal genomics industry has been bruised by the US Congress, but embracing sensible regulation could shift it to the heart of clinical medicine
(Jul 29, 2010)
Rosetta Genomics to Present at Leerink Swan's Life Science Tools and Diagnostics Roundtable Conference
PHILADELPHIA & REHOVOT, Israel----Rosetta Genomics, Ltd. a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be participating in a panel discussion entitled, Issues and Opportunities in Molecular Diagnostics, at 11:00 a.m. and will be presenting a corporate update at 1:10 p.m. at Leerink Swans Life Science ...
(Jul 30, 2010)
Pathwork Diagnostics Partners with Leading Pharmaceutical Company to Discover Molecular Diagnostics for Cancer
REDWOOD CITY, Calif.----Pathwork Diagnostics Inc., a molecular diagnostics company focused on oncology, today announced that it has entered into a research collaboration with Novartis.
(Jul 30, 2010)
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Continued Expansion of Stellar's Global Strategy
(Jul 30, 2010)
Rosetta Genomics to Present at Leerink Swans Life Science Tools and Diagnostics Roundtable Conference
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG) a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be participating in a panel discussion entitled, Issues and Opportunities in Molecular Diagnostics, at 11:00 a.m. and will be presenting a corporate update at 1:10 p.m. at ...
(Jul 30, 2010)
Personal genomics links [Genetic Future]
This week was pretty hectic, so there were plenty of useful or interesting links from the personal genomics world that I didn't have time to write about in detail. Feel free to share your own suggestions in the comments. Responses to the Congress/FDA crack-down As all of you will be aware, the big news this week revolved around the debate over the regulatory future of the direct-to-consumer (DTC ...
(Jul 30, 2010)
Pathwork Diagnostics, Novartis Team Up for Cancer Biomarker Discovery
NEW YORK (GenomeWeb News) Cancer molecular diagnostics developer Pathwork Diagnostics announced today a collaboration with Novartis for the discovery of cancer biomarkers.
(Jul 30, 2010)
Rosetta Licenses Greek miRNA Dx Rights to Genekor
Rosetta Genomics said this week that it has signed a deal making Genekor the exclusive distributor of its three microRNA-based diagnostics in Greece.
(Jul 30, 2010)
Adoption of In Silico Tools in Drug Discovery Accelerates Time to Market and Confers Cost Advantages, Notes Frost ...
MOUNTAIN VIEW, Calif., July 30 /PRNewswire/ -- Due to the decrease in the rollout of blockbuster drugs in recent years, the focus has intensified on the development of in silico screening systems. There is greater emphasis on reducing the cycle time significantly to shorten the time to market for new drugs. The limited time frame granted for the generation of blockbuster drugs is an important ...
(Jul 30, 2010)
People In The News
NEW YORK (GenomeWeb News) Becton Dickinson has given company President Vincent Forlenza the additional job of chief operating officer, and it has added Christopher Jones to serve on its board of directors.
(Jul 30, 2010)
Golden Helix Looks to Expand User Base Beyond GWAS with SVS 7 Upgrade
A version of this story previously ran in BioInform's sister publication BioArray News. Seeking to broaden its customer base beyond researchers conducting genome-wide association studies, Golden Helix last week launched an upgrade of its SNP & Variation Suite 7 software that includes features expected to appeal to cytogeneticists and researchers in the agricultural biotech market.
(Jul 30, 2010)
Q&A: EBI's Maria Victoria Schneider on Bioinformatics Training for Life Science Researchers
Last November , a group of biologists, computational scientists, physicists, and chemists held a workshop to discuss the challenges of providing training for end-users of bioinformatics tools.
(Jul 30, 2010)
New Products
Gentel Biosciences started sales this week of its APiX Disease Profiling Kit , a single-capture antibody array and detection kit that the company said can be used for profiling hundreds of disease-related proteins across multiple disease states.
(Jul 30, 2010)
Funding Update
The project will look at the feasibility of using photochemical linkers to immobilize small molecules, synthetic peptides, purified proteins, and crude natural extracts on electrochemical sensor arrays.
(Jul 30, 2010)
Mediomics Receives $460K Grant to Improve Protein-Detection Assay and Cardiovascular Biomarker Panel
St. Louis, Mo.-based biotech firm Mediomics announced this week that it has received a $460,000 renewal of an STTR Phase II grant from the National Institute of General Medical Sciences to develop its Pincer product, a homogeneous antibody-based protein detection assay.
(Jul 30, 2010)
Complete Genomics, Inc. Files Registration Statement for Proposed Initial Public Offering
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Complete Genomics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its common stock. The shares of common stock to be sold in this offering are proposed to be sold solely by Complete Genomics, Inc. UBS ...
(Jul 30, 2010)
Mountain View's Complete Genomics to make Wall Street debut
Firm's goal: Push cost of genome sequencing to less than $1,000
(Jul 30, 2010)
Paperback Row
Paperback books of particular interest.
(Jul 30, 2010)
Panel reviews chancellor applicants
NASHVILLE Deputy Gov. John Morgan is one of six candidates vying to become the next chancellor of the Tennessee Board of Regents.
(Jul 31, 2010)
Complete Genomics files registration statement on Form S-1 with SEC
Complete Genomics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. The shares of common stock to be sold in this offering are proposed to be sold solely by Complete Genomics, Inc.
(Jul 31, 2010)
|
